Written Question · S4W-19957 · Session 4
How the rare diseases fund will be affected by the new processes for Scottish Medicines Consortium approval of orphan and ultra-orphan medi…
The question
To ask the Scottish Government how the rare diseases fund will be affected by the new processes for Scottish Medicines Consortium approval of orphan and ultra-orphan medicines.
The answer
As part of work ongoing between Scottish Government and NHSScotland on the financial implications of the change in approach being adopted by the Scottish Medicines Consortium (SMC) consideration is being given as to how the Rare Conditions Medicines Fund will best support the anticipated increase in medicines accepted by the SMC.
In the Official Report
No contribution in the Official Report cites S4W-19957 by reference.